• OPEN AN ACCOUNT
Indian Indices
Sensex
76,470.70 -473.58
( -0.62%)
Global Indices
Nasdaq
52,794.59 -412.31
(-0.77%)
Dow Jones
7,653.60 -53.54
(-0.69%)
Hang Seng
64,415.54 -1,799.80
(-2.72%)
Nikkei 225
10,792.77 -31.49
(-0.29%)
Forex
USD-INR
95.24 -0.24
(-0.25%)
EUR-INR
110.49 -0.08
(-0.07%)
GBP-INR
128.99 -0.20
(-0.15%)
JPY-INR
0.60 0.00
(-0.03%)

EQUITY - MARKET SCREENER

ICICI Bank Ltd
Industry :  Banks - Private Sector
BSE Code
ISIN Demat
Book Value()
532174
INE090A01021
483.366911
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ICICIBANK
19.76
1031137.6
EPS(TTM)
Face Value()
Div & Yield %
72.71
2
0.83
 

Bacil Pharma standalone net profit rises 3000.00% in the March 2026 quarter
May 23,2026
Net profit of Bacil Pharma rose 3000.00% to Rs 0.62 crore in the quarter ended March 2026 as against Rs 0.02 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit rose 290.00% to Rs 1.56 crore in the year ended March 2026 as against Rs 0.40 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.